MGTX CIK: 1735438

MeiraGTx Holdings plc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
183
FY22:
154
FY23:
160
FY24:
124
FY25:
91.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
137
FY22:
164
FY23:
167
FY24:
146
FY25:
153
Total assets
Change from FY21 to FY25
millions USD
FY21:
320
FY22:
318
FY23:
327
FY24:
270
FY25:
244

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
68.1
FY22:
82.1
FY23:
67.1
FY24:
60.8
FY25:
123
(negative)
Change from FY21 to FY25
millions USD
FY21:
66.6
FY22:
118
FY23:
121
FY24:
141
FY25:
128
(positive)
Change from FY21 to FY25
millions USD
FY21:
185
FY22:
118
FY23:
138
FY24:
67.8
FY25:
−5.79
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
320
FY22:
318
FY23:
327
FY24:
270
FY25:
244

All amounts in millions USD Data source:SEC EDGAR